BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 11602714)

  • 1. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus.
    Haynes LM; Moore DD; Kurt-Jones EA; Finberg RW; Anderson LJ; Tripp RA
    J Virol; 2001 Nov; 75(22):10730-7. PubMed ID: 11602714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus.
    Ehl S; Bischoff R; Ostler T; Vallbracht S; Schulte-Mönting J; Poltorak A; Freudenberg M
    Eur J Immunol; 2004 Apr; 34(4):1146-53. PubMed ID: 15048726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.
    Kurt-Jones EA; Popova L; Kwinn L; Haynes LM; Jones LP; Tripp RA; Walsh EE; Freeman MW; Golenbock DT; Anderson LJ; Finberg RW
    Nat Immunol; 2000 Nov; 1(5):398-401. PubMed ID: 11062499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.
    Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S
    Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways.
    Haeberle HA; Takizawa R; Casola A; Brasier AR; Dieterich HJ; Van Rooijen N; Gatalica Z; Garofalo RP
    J Infect Dis; 2002 Nov; 186(9):1199-206. PubMed ID: 12402188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease.
    Tal G; Mandelberg A; Dalal I; Cesar K; Somekh E; Tal A; Oron A; Itskovich S; Ballin A; Houri S; Beigelman A; Lider O; Rechavi G; Amariglio N
    J Infect Dis; 2004 Jun; 189(11):2057-63. PubMed ID: 15143473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4-mediated activation of murine mast cells.
    McCurdy JD; Lin TJ; Marshall JS
    J Leukoc Biol; 2001 Dec; 70(6):977-84. PubMed ID: 11739561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infection.
    Bernheiden M; Heinrich JM; Minigo G; Schütt C; Stelter F; Freeman M; Golenbock D; Jack RS
    J Endotoxin Res; 2001; 7(6):447-50. PubMed ID: 11753215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model.
    Cyr SL; Angers I; Guillot L; Stoica-Popescu I; Lussier M; Qureshi S; Burt DS; Ward BJ
    Vaccine; 2009 Jan; 27(3):421-30. PubMed ID: 19013492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication.
    Marr N; Turvey SE
    Innate Immun; 2012 Dec; 18(6):856-65. PubMed ID: 22535679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll and Toll-like proteins: an ancient family of receptors signaling infection.
    Imler JL; Hoffmann JA
    Rev Immunogenet; 2000; 2(3):294-304. PubMed ID: 11256741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria.
    Laflamme N; Echchannaoui H; Landmann R; Rivest S
    Eur J Immunol; 2003 Apr; 33(4):1127-38. PubMed ID: 12672079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.
    Oyama J; Blais C; Liu X; Pu M; Kobzik L; Kelly RA; Bourcier T
    Circulation; 2004 Feb; 109(6):784-9. PubMed ID: 14970116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components.
    Laflamme N; Rivest S
    FASEB J; 2001 Jan; 15(1):155-163. PubMed ID: 11149903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus-induced immunoprotection and immunopathology.
    Durbin JE; Durbin RK
    Viral Immunol; 2004; 17(3):370-80. PubMed ID: 15357903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
    Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
    J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.